Home » Stocks » BICX

BioCorRx Inc. (BICX)

Stock Price: $2.00 USD 0.00 (0.00%)
Updated Feb 23, 2021 4:00 PM EST - End of day
Market Cap 12.42M
Revenue (ttm) 162,847
Net Income (ttm) -3.77M
Shares Out 5.39M
EPS (ttm) -0.70
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 23
Last Price $2.00
Previous Close $2.00
Change ($) 0.00
Change (%) 0.00%
Day's Open -
Day's Range 0.00 - 0.00
Day's Volume -
52-Week Range 0.16 - 3.12


GlobeNewsWire - 1 month ago

ANAHEIM, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...

About BICX

BioCorRx, through its subsidiaries, provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers in the United States. It distributes and licenses BioCorRx recovery program, a medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant. The company is also developing BICX101, an injectable naltrexone product; and BICX102, an implantable naltrexone implant for the treatment of alcohol and opioid addiction. It distributes its program to heal... [Read more...]

Medical Care Facilities
Brady Granier
United States
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

In 2019, BioCorRx's revenue was $240,259, a decrease of -36.21% compared to the previous year's $376,656. Losses were -$6.04 million, -7.25% less than in 2018.

Financial Statements